ELIZABETH WALKUP: Open Payments
NPI 1356439301 · FRANKLIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 20 payments from 9 companies in 2025. Trend: 2023 $491 · 2024 $679 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $64 |
| Novo Nordisk Inc | 3 | $61 |
| PFIZER INC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Dynavax Technologies Corporation | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: PAXLOVID, OTEZLA, Kerendia, VRAYLAR, Heplisav-B, REXULTI, SHINGRIX, Ozempic.
Industry payments across KY — which companies pay providers there.
